Bayer stops Clicks selling cheaper generic blood thinning drug
After the initial patent expired two rival companies launched generic versions of the medicine for sale in South Africa.
Source: moneyweb.co.za
Stay updated with breaking news from Alpha Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After the initial patent expired two rival companies launched generic versions of the medicine for sale in South Africa.
Bayer approached the Court of Commissioner of Patents in Gauteng last year to stop Clicks from selling the tablets
The judge took over a year to rule in “urgent application”
Judge Colleen Collis reserved judgment in April 2022 in a matter between Bayer and Clicks
Kwazakhele residents finally have a private clinic dedicated to their health needs.